Pharma-Bio Serv Statistics
Total Valuation
Pharma-Bio Serv has a market cap or net worth of 10.09 million. The enterprise value is -2.19 million.
Market Cap | 10.09M |
Enterprise Value | -2.19M |
Important Dates
The next estimated earnings date is Friday, June 13, 2025.
Earnings Date | Jun 13, 2025 |
Ex-Dividend Date | Feb 28, 2025 |
Share Statistics
Pharma-Bio Serv has 22.93 million shares outstanding. The number of shares has decreased by -0.17% in one year.
Current Share Class | n/a |
Shares Outstanding | 22.93M |
Shares Change (YoY) | -0.17% |
Shares Change (QoQ) | -0.05% |
Owned by Insiders (%) | 54.92% |
Owned by Institutions (%) | 1.49% |
Float | 8.40M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 4.00 |
PS Ratio | 1.05 |
PB Ratio | 0.84 |
P/TBV Ratio | 0.84 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 4.40 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 1.16 |
Financial Position
The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.01.
Current Ratio | 4.54 |
Quick Ratio | 4.42 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | -0.08 |
Interest Coverage | -29.71 |
Financial Efficiency
Return on equity (ROE) is -3.81% and return on invested capital (ROIC) is -4.42%.
Return on Equity (ROE) | -3.81% |
Return on Assets (ROA) | -3.33% |
Return on Invested Capital (ROIC) | -4.42% |
Return on Capital Employed (ROCE) | -7.44% |
Revenue Per Employee | 128,006 |
Profits Per Employee | -6,645 |
Employee Count | 75 |
Asset Turnover | 0.54 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.14% in the last 52 weeks. The beta is 0.64, so Pharma-Bio Serv's price volatility has been lower than the market average.
Beta (5Y) | 0.64 |
52-Week Price Change | -37.14% |
50-Day Moving Average | 0.50 |
200-Day Moving Average | 0.57 |
Relative Strength Index (RSI) | 36.87 |
Average Volume (20 Days) | 1,954 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Pharma-Bio Serv had revenue of 9.60 million and -498,364 in losses. Loss per share was -0.02.
Revenue | 9.60M |
Gross Profit | 2.75M |
Operating Income | -941,478 |
Pretax Income | -488,026 |
Net Income | -498,364 |
EBITDA | -916,014 |
EBIT | -941,478 |
Loss Per Share | -0.02 |
Balance Sheet
The company has 12.43 million in cash and 153,994 in debt, giving a net cash position of 12.28 million or 0.54 per share.
Cash & Cash Equivalents | 12.43M |
Total Debt | 153,994 |
Net Cash | 12.28M |
Net Cash Per Share | 0.54 |
Equity (Book Value) | 12.00M |
Book Value Per Share | 0.52 |
Working Capital | 12.11M |
Cash Flow
In the last 12 months, operating cash flow was -1.72 million and capital expenditures -158,923, giving a free cash flow of -1.88 million.
Operating Cash Flow | -1.72M |
Capital Expenditures | -158,923 |
Free Cash Flow | -1.88M |
FCF Per Share | -0.08 |
Margins
Gross margin is 28.63%, with operating and profit margins of -9.81% and -5.19%.
Gross Margin | 28.63% |
Operating Margin | -9.81% |
Pretax Margin | -5.08% |
Profit Margin | -5.19% |
EBITDA Margin | -9.54% |
EBIT Margin | -9.81% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 17.05%.
Dividend Per Share | 0.08 |
Dividend Yield | 17.05% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.17% |
Shareholder Yield | 17.22% |
Earnings Yield | -4.94% |
FCF Yield | -18.64% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Pharma-Bio Serv has an Altman Z-Score of 4.46.
Altman Z-Score | 4.46 |
Piotroski F-Score | n/a |